Gene Therapy for Hemophilia Becomes a Reality

(MedPage Today) -- Earlier this year we reported on FDA's approval of valoctocogene roxaparvovec (Roctavian) for adults with severe hemophilia A. In this story, we provide an update on what has happened since. Two gene therapies have now been...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news